BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 30232132)

  • 1. Specificity of QuantiFERON-TB Plus, a New-Generation Interferon Gamma Release Assay.
    Siegel SAR; Cavanaugh M; Ku JH; Kawamura LM; Winthrop KL
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30232132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.
    Theel ES; Hilgart H; Breen-Lyles M; McCoy K; Flury R; Breeher LE; Wilson J; Sia IG; Whitaker JA; Clain J; Aksamit TR; Escalante P
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients.
    Ryu MR; Park MS; Cho EH; Jung CW; Kim K; Kim SJ; Oh HY; Huh W; Jang HR; Koh WJ; Park HY; Kim YH; Sinn DH; Choi JO; Joh JW; Kim JM; Kim SJ; Park JB; Kang ES
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30135226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
    Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
    Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Results of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus Assays for Detection of Tuberculosis Infection in Clinical Samples.
    Won D; Park JY; Kim HS; Park Y
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31969422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing QuantiFERON-TB Gold Plus with Other Tests To Diagnose Mycobacterium tuberculosis Infection.
    Venkatappa TK; Punnoose R; Katz DJ; Higgins MP; Banaei N; Graviss EA; Belknap RW; Ho CS
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31462550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in the Diagnosis of
    Xu Y; Yang Q; Zhou J; Zhou F; Hezhang Y; Gao Y; Shao L; Shi J; Ruan Q; Zhang W
    Microbiol Spectr; 2022 Apr; 10(2):e0187021. PubMed ID: 35234509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre verification study of the QuantiFERON
    Pieterman ED; Liqui Lung FG; Verbon A; Bax HI; Ang CW; Berkhout J; Blaauw G; Brandenburg A; van Burgel ND; Claessen A; van Dijk K; Heron M; Hooghiemstra M; Leussenkamp-Hummelink R; van Lochem E; van Loo IHM; Mulder B; Ott A; Pontesilli O; Reuwer A; Rombouts P; Saegeman V; Scholing M; Vainio S; de Steenwinkel JEM
    Tuberculosis (Edinb); 2018 Jan; 108():136-142. PubMed ID: 29523314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QuantiFERON-TB Gold Plus Is a More Sensitive Screening Tool than QuantiFERON-TB Gold In-Tube for Latent Tuberculosis Infection among Older Adults in Long-Term Care Facilities.
    Chien JY; Chiang HT; Lu MC; Ko WC; Yu CJ; Chen YH; Hsueh PR
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29793966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First evaluation of QuantiFERON-TB Gold Plus performance in contact screening.
    Barcellini L; Borroni E; Brown J; Brunetti E; Campisi D; Castellotti PF; Codecasa LR; Cugnata F; Di Serio C; Ferrarese M; Goletti D; Lipman M; Rancoita PM; Russo G; Tadolini M; Vanino E; Cirillo DM
    Eur Respir J; 2016 Nov; 48(5):1411-1419. PubMed ID: 27390280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In Tube in the diagnosis of pulmonary tuberculosis].
    Wang XY; Su BY; Chen ZY; Kuang HB; Guan P; Cao ZZ; Tan YJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 May; 45(5):445-452. PubMed ID: 35527459
    [No Abstract]   [Full Text] [Related]  

  • 13. Sensitivity and specificity of QuantiFERON-TB Gold Plus compared with QuantiFERON-TB Gold In-Tube and T-SPOT.TB on active tuberculosis in Japan.
    Takasaki J; Manabe T; Morino E; Muto Y; Hashimoto M; Iikura M; Izumi S; Sugiyama H; Kudo K
    J Infect Chemother; 2018 Mar; 24(3):188-192. PubMed ID: 29108749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis.
    Petruccioli E; Vanini V; Chiacchio T; Cuzzi G; Cirillo DM; Palmieri F; Ippolito G; Goletti D
    Tuberculosis (Edinb); 2017 Sep; 106():38-43. PubMed ID: 28802403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fourth-Generation QuantiFERON-TB Gold Plus: What Is the Evidence?
    Shafeque A; Bigio J; Hogan CA; Pai M; Banaei N
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32493779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon-γ release assays: A systematic review and meta-analysis.
    Pourakbari B; Mamishi S; Benvari S; Mahmoudi S
    Adv Med Sci; 2019 Sep; 64(2):437-443. PubMed ID: 31586819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma release assays in patients with Mycobacterium kansasii pulmonary infection: A retrospective survey.
    Sato R; Nagai H; Matsui H; Kawabe Y; Takeda K; Kawashima M; Suzuki J; Ohshima N; Masuda K; Yamane A; Tamura A; Akagawa S; Ohta K
    J Infect; 2016 Jun; 72(6):706-712. PubMed ID: 27025204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in interferon-γ production between QFT-Plus and QFT-GIT assays in TB contact investigation.
    Tsuyuzaki M; Igari H; Okada N; Suzuki K
    Respir Investig; 2019 Nov; 57(6):561-565. PubMed ID: 31402331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].
    Matsumoto T; Yamazaki T
    Kekkaku; 2014 Sep; 89(9):743-55. PubMed ID: 25730946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.